These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26636927)

  • 1. Factors associated with initiation of antiretroviral therapy among HIV-positive people who use injection drugs in a Canadian setting.
    Joseph B; Wood E; Hayashi K; Kerr T; Barrios R; Parashar S; Richardson L; Dobrer S; Guillemi S; Montaner J; Milloy MJ
    AIDS; 2016 Mar; 30(6):925-32. PubMed ID: 26636927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and virological failure among HIV-infected people who inject drugs on antiretroviral treatment in China: An observational cohort study.
    Zhao Y; Zhang M; Shi CX; Huang J; Zhang F; Rou K; Wu Z
    Drug Alcohol Depend; 2017 Jan; 170():189-197. PubMed ID: 27987476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Factors Associated with Used Syringe Lending Among HIV-Positive Antiretroviral Therapy-Naïve People Who Inject Drugs in a Canadian Setting.
    Blumenkrans E; Socías ME; Richardson L; Kerr T; Shoveller J; Montaner J; Milloy MJ
    AIDS Behav; 2020 Jul; 24(7):2163-2168. PubMed ID: 32026249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural, social and structural-level risk factors for developing AIDS among HIV-positive people who use injection drugs in a Canadian setting, 1996-2017.
    Ickowicz S; Dong H; Ti L; Nolan S; Fairbairn N; Barrios R; Milloy MJ
    AIDS Care; 2020 Oct; 32(10):1262-1267. PubMed ID: 32476442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis.
    Azar P; Wood E; Nguyen P; Luma M; Montaner J; Kerr T; Milloy MJ
    BMC Infect Dis; 2015 Apr; 15():193. PubMed ID: 25927573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of patterns of methadone use with antiretroviral therapy discontinuation: a prospective cohort study.
    Bach P; Wood E; Dong H; Guillemi S; Kerr T; Montaner J; Milloy MJ
    BMC Infect Dis; 2015 Nov; 15():537. PubMed ID: 26586238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
    Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
    HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
    Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
    Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
    Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
    Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.
    Joseph B; Kerr T; Puskas CM; Montaner J; Wood E; Milloy MJ
    AIDS Care; 2015; 27(9):1128-36. PubMed ID: 25915438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study.
    Ahamad K; Hayashi K; Nguyen P; Dobrer S; Kerr T; Schütz CG; Montaner JS; Wood E
    Lancet HIV; 2015 Oct; 2(10):e445-50. PubMed ID: 26423652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Client and Provider Perspectives on Antiretroviral Treatment Uptake and Adherence Among People Who Inject Drugs in Indonesia, Ukraine and Vietnam: HPTN 074.
    Go VF; Hershow RB; Kiriazova T; Sarasvita R; Bui Q; Latkin CA; Rose S; Hamilton E; Lancaster KE; Metzger D; Hoffman IF; Miller WC
    AIDS Behav; 2019 Apr; 23(4):1084-1093. PubMed ID: 30306437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.
    Small W; Milloy MJ; McNeil R; Maher L; Kerr T
    AIDS Res Ther; 2016; 13():26. PubMed ID: 27462360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
    Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
    Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.
    Milloy MJ; Kerr T; Buxton J; Rhodes T; Krusi A; Guillemi S; Hogg R; Montaner J; Wood E
    J Acquir Immune Defic Syndr; 2012 Apr; 59(4):393-9. PubMed ID: 22134149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting.
    Milloy MJ; King A; Kerr T; Adams E; Samji H; Guillemi S; Wood E; Montaner J
    J Int AIDS Soc; 2016; 19(1):20617. PubMed ID: 27094914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compulsory drug detention exposure is associated with not receiving antiretroviral treatment among people who inject drugs in Bangkok, Thailand: a cross-sectional study.
    Hayashi K; Ti L; Avihingsanon A; Kaplan K; Suwannawong P; Wood E; Montaner JS; Kerr T
    Subst Abuse Treat Prev Policy; 2015 May; 10():16. PubMed ID: 25943881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of opioid agonist therapy with the initiation of antiretroviral therapy - a systematic review.
    Mlunde LB; Sunguya BF; Mbwambo JK; Ubuguyu OS; Yasuoka J; Jimba M
    Int J Infect Dis; 2016 May; 46():27-33. PubMed ID: 27044520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
    Lappalainen L; Nolan S; Dobrer S; Puscas C; Montaner J; Ahamad K; Dong H; Kerr T; Wood E; Milloy MJ
    Addiction; 2015 Aug; 110(8):1330-9. PubMed ID: 25940906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.